Status:
COMPLETED
ARM-ED: Advanced Respiratory Monitoring Events in Drug Toxicity
Lead Sponsor:
NHS Greater Glasgow and Clyde
Collaborating Sponsors:
Pneumowave Ltd
Conditions:
Respiratory Insufficiency
Overdose of Opiate
Eligibility:
All Genders
16+ years
Brief Summary
There is a drug-related death crisis in Scotland. The majority of these deaths have involved the misuse of opiates (e.g. heroin) and benzodiazepines (e.g. valium) which cause an individual to stop bre...
Detailed Description
This study aims to assess if it is feasible to collect respiratory waveform data using an advanced respiratory monitoring device named Pneumowave and whether the device is user friendly in terms of nu...
Eligibility Criteria
Inclusion
- Group 1 - Acute toxicity group
- Presentation to ED due to presumed overdose of drug with potential for respiratory depression (intentional, accidental, recreational, therapeutic excess)
- At least one of GCS \<15 or respiratory depression or risk of deterioration of GCS or respiration.
- Age \>16 years
- Are willing and able to give informed consent or have available next of Kin to provide informed consent on the participant's behalf
- Able (in the Investigators opinion) and willing to comply with all study requirements
- Group 2 - PSA group
- Patient undergoing procedural sedation and anaesthesia in ED
- Age \>16 years
- Are willing and able to give informed consent
- Able (in the Investigators opinion) and willing to comply with all study requirements
- Can speak and read English
Exclusion
- Group 1 - Acute toxicity group
- Unable to provide consent and no next of kin to provide consent on participant's behalf
- Impaired consciousness / respiratory suppression most likely due to cause other than acute drug use
- Condition primarily related to alcohol use and no evidence of acute drug use
- Condition due to withdrawal of drugs / alcohol.
- Treating clinician deems patient inappropriate to be included in study
- Group 2 - PSA group
- Unable to provide consent
- Treating clinician deems patient inappropriate to be included in study
Key Trial Info
Start Date :
June 8 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 7 2024
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT05358132
Start Date
June 8 2022
End Date
March 7 2024
Last Update
June 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emergency Department, Queen Elizabeth University Hospital
Glasgow, United Kingdom, G51 4FT